https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-02-15 / Leuk Lymphoma 2022 Jul;63(7):1733-1737
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-02-15 / Leuk Lymphoma 2022 Jul;63(7):1733-17372022-02-15 00:00:002022-02-15 00:00:00Wilms‘ tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory malignant lymphoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-19 / Cancer Sci. 2019 Mar;110(3):849-857
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-19 / Cancer Sci. 2019 Mar;110(3):849-8572019-02-19 00:00:002019-07-01 08:21:29Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-29 / J. Immunol. 2016 08;197(3):795-806
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-29 / J. Immunol. 2016 08;197(3):795-8062016-06-29 00:00:002019-02-15 08:48:41NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-13 / Cell Death Discov 2016;2:16039
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-13 / Cell Death Discov 2016;2:160392016-06-13 00:00:002016-06-13 00:00:00Comparison of biological effects of modulated electro-hyperthermia and conventional heat treatment in human lymphoma U937 cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-23 / Viruses 2015 Dec;8(1)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-23 / Viruses 2015 Dec;8(1)2015-12-23 00:00:002019-02-15 09:19:11Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-01-22 / Br. J. Haematol. 2015 May;169(3):356-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-01-22 / Br. J. Haematol. 2015 May;169(3):356-672015-01-22 00:00:002019-02-15 08:45:29Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2013-05-30 / Acta Med Iran 2013 May;51(5):284-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2013-05-30 / Acta Med Iran 2013 May;51(5):284-82013-05-30 00:00:002019-02-15 08:48:37Vaccination of diffuse large B- cell lymphoma patients with antigen-primed dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-12-01 / Clin. Exp. Immunol. 2012 Dec;170(3):291-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-12-01 / Clin. Exp. Immunol. 2012 Dec;170(3):291-92012-12-01 00:00:002019-02-15 08:48:38Enhanced therapeutic effect of B cell-depleting anti-CD20 antibodies upon combination with in-situ dendritic cell vaccination in advanced lymphoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-04-01 / G Ital Dermatol Venereol 2011 Apr;146(2):103-13
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-04-01 / G Ital Dermatol Venereol 2011 Apr;146(2):103-132011-04-01 00:00:002019-02-15 08:48:39Dendritic cells and cutaneous T-cell lymphomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-30 / Cancer Res. 2010 Nov;70(22):9062-72
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-30 / Cancer Res. 2010 Nov;70(22):9062-722010-09-30 00:00:002019-02-15 08:48:39Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death
